Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Two cases of a rare skin condition were successfully treated with laser therapy, offering a non-surgical treatment option.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Amphetamines may not directly cause hair loss, as the type of thinning seen with their use differs from severe alopecia.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

The document concludes that diagnosing and managing plaque psoriasis, particularly in sensitive areas, is challenging and requires careful differentiation from similar skin conditions.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

Amphetamine use may not cause hair loss, "geezer" traits are normal aging, not all educated older people are stereotypes, and metronidazole can rarely cause lung disease.

Amphetamines may not directly cause hair loss.

Some medications caused temporary health issues that improved after stopping the drugs, but two patients died from liver problems linked to carbamazepine.

Monocytes might be linked to hair loss after COVID-19.

Nivolumab can cause hair loss as a rare side effect.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

COVID-19 infection can significantly cause temporary hair loss.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Polynucleotide gel injections help reduce hair loss and increase hair thickness in people with pattern hair loss, with few side effects.

A child's hair loss after Kawasaki disease may help understand the disease's autoimmune causes.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

A patient lost all their hair while on rheumatoid arthritis medication.